Most AI conversations in healthcare still focus on the future.
Robotic surgery, diagnostics and predictive medicine tend to dominate the discussion. But a more immediate challenge already exists: people need clear, trustworthy information, healthcare staff are under administrative pressure, and many patients still do not trust generic AI systems when health is involved.
This is where ReganByte becomes especially interesting.
Founded in 2024 by David O’Regan, the County Wicklow-based company is building AI systems designed for healthcare organisations, patient advocacy groups, clinics and research-related use cases. What stands out is not only the technology itself, but the company’s trust-first positioning.
According to its public messaging, ReganByte emphasises:
- GDPR and EU AI Act compliance
- Ireland and EU-based infrastructure
- clinically validated systems
- trustworthy, auditable AI
That framing matters.
It suggests a model of healthcare AI that is not built for hype or broad generalisation, but for specific environments where trust, oversight and responsible implementation are central.
One notable example is Before My Visit, a project designed to help people managing chronic illnesses organise medical histories, symptoms, medications and treatment journeys before appointments. This reflects a practical use of AI: not replacing clinical expertise, but reducing friction and improving communication for people navigating complex healthcare systems.
At AI Dubliners, we see companies like ReganByte as part of a broader European shift.
The next wave of AI may not be defined only by larger models or more general capabilities. It may also be shaped by focused companies building specialised, human-centred and trust-first systems for real-world use.
ReganByte is part of that movement.
